On this page
EPL lifts near-term growth outlook as beauty and cosmetics becomes a key expansion lever
Our read
EPL’s higher 16–18% growth outlook signals accelerating demand for beauty and personal-care packaging, making capacity, customer mix and format innovation key execution priorities.
Watch
Quarterly revenue growth versus the 16–18% guidance range and management commentary on order visibility.
The report,
EPL raised near-term revenue growth guidance to 16-18% after 25% June-quarter topline growth, positioning beauty and cosmetics as its second growth engine in India. Its proposed Indovida merger, awaiting regulatory clearances, would expand packaging formats and emerging-market reach.
One email each morning: the day’s top moves in Indian retail, why each matters and what to watch. Free. Stop any time.
Reported figures
From the report. Source details below
| Beauty and cosmetics growth potential of | up to 20% |
|---|---|
| Indovida June-quarter volume growth: | 12% |
| Indovida June-quarter EBITDA growth: | 62% |
| 21 facilities across | 11 countries |
| More than | 6,000 employees |
| More than | 1,200 customers |
Also in the report
- 35% global oral-care tube market share
- 8% personal-care packaging market share
- Polymer raw-material prices rose almost 100% in the June quarter
- More than 9 billion tubes produced annually
Other figures
- 20% margin guidance
Why it matters to operators
The proposed Indovida merger could expand EPL’s format portfolio and emerging-market footprint, supporting its ambition to scale beauty and cosmetics into a second growth engine.
What to watch next
- Personal-care packaging share progression toward the 16% four-to-five-year target.
- Beauty/customer-launch wins, especially premium skincare, cosmetics and dermaceutical accounts.
- Indovida merger approval, closing timeline, integration costs and disclosed revenue synergies.
- EBITDA margin movement: evidence that higher-value beauty mix offsets resin, laminate and freight volatility.
- Capacity additions, utilization levels and capital-expenditure guidance.
Show 2 more
- Sustainability regulations or major customer mandates requiring recyclable or recycled-content packaging.
- Demand trends in key emerging markets and the oral-care category, which remains the cash-generating base.
Likely next moves
Our read of what comes next — analysis, not reported by the source.
- Prioritize beauty, cosmetics, skincare and derma brands where premium decoration, barrier tubes and smaller pack sizes create higher revenue per unit.
- Use the Indovida combination to cross-sell non-tube formats and offer multinational customers regional supply across Latin America, Africa and other emerging markets.
- Add or repurpose capacity near high-growth personal-care customers while protecting service levels for the legacy oral-care base.
- Increase investment in recyclable, mono-material and PCR-content packaging, as sustainability requirements become a key vendor-selection criterion for beauty brands.
- Pursue multi-year supply agreements with fast-growing local beauty brands to reduce dependence on a small set of global FMCG customers.
The counter-case
The case against this reading — not reported by the source.
The 16–18% growth outlook may be flattered by a strong June quarter, favorable comparisons, customer restocking, or price/mix rather than a durable volume-led acceleration. Beauty and cosmetics is attractive but highly competitive, with global packaging incumbents, brand-owner bargaining power, frequent design changes, and sustainability demands that can compress margins and require sustained capex. Doubling personal-care packaging share to 16% over four to five years is ambitious and may require winning business from entrenched suppliers or accepting lower-margin contracts. The Indovida merger could add formats and geographic reach, but integration complexity, leverage, dilution, regulatory approvals, and cross-border execution could outweigh the strategic benefits.